Tech Company Financing Transactions
Jasper Therapeutics Funding Round
Jasper Therapeutics, based in Menlo Park, raised $14.1 million from Roche Venture Fund and private investors.
Transaction Overview
Company Name
Announced On
1/13/2020
Transaction Type
Venture Equity
Amount
$14,100,000
Round
Series A
Investors
Roche Venture Fund (Lead Investor)
Proceeds Purpose
The company plans to use the proceeds to advance and expand the study of its lead clinical asset, JSP191.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3000 Sand Hill Rd. B1-145
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper's lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Lis
Chief Financial Officer
Jeet Mahal
Co-Founder
Judith Shizuru
VP - Operations
Susan Prohaska
VP - R & D
Wendy Pang
Browse more venture capital transactions:
Prev: 1/13/2020: Virta Health venture capital transaction
Next: 1/13/2020: New Age Meats venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs